Last reviewed · How we verify
GSK Biologicals' Polio Sabin™
GSK Biologicals' Polio Sabin™ is a Biologic drug developed by GlaxoSmithKline. It is currently in Phase 3 development. Also known as: OPV.
At a glance
| Generic name | GSK Biologicals' Polio Sabin™ |
|---|---|
| Also known as | OPV |
| Sponsor | GlaxoSmithKline |
| Modality | Biologic |
| Phase | Phase 3 |
Approved indications
Common side effects
- Pain
- Irritability
- Swelling
- Pyrexia
- Erythema
- Somnolence
- Decreased appetite
- Fever (rectal temperature ≥ 38.5°C)
- Rhinitis
- Upper respiratory tract infection
- Gastroenteritis
- Drowsiness
Key clinical trials
- Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™ (PHASE3)
- Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049) (PHASE3)
- Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants (PHASE2)
- Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants (PHASE2)
- Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines (PHASE3)
- Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine (PHASE3)
- Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GSK Biologicals' Polio Sabin™ CI brief — competitive landscape report
- GSK Biologicals' Polio Sabin™ updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about GSK Biologicals' Polio Sabin™
What is GSK Biologicals' Polio Sabin™?
GSK Biologicals' Polio Sabin™ is a Biologic drug developed by GlaxoSmithKline.
Who makes GSK Biologicals' Polio Sabin™?
GSK Biologicals' Polio Sabin™ is developed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).
Is GSK Biologicals' Polio Sabin™ also known as anything else?
GSK Biologicals' Polio Sabin™ is also known as OPV.
What development phase is GSK Biologicals' Polio Sabin™ in?
GSK Biologicals' Polio Sabin™ is in Phase 3.
What are the side effects of GSK Biologicals' Polio Sabin™?
Common side effects of GSK Biologicals' Polio Sabin™ include Pain, Irritability, Swelling, Pyrexia, Erythema, Somnolence.
Related
- Manufacturer: GlaxoSmithKline — full pipeline
- Also known as: OPV
- Compare: GSK Biologicals' Polio Sabin™ vs similar drugs
- Pricing: GSK Biologicals' Polio Sabin™ cost, discount & access